NEW YORK (GenomeWeb News) — OncoMethylome will use BioTrove’s OpenArray PCR screening technology to develop gene-methylation cancer biomarkers, BioTrove said today.
 
Terms of the multi-year supply agreement call for BioTrove to provide its OpenArray nanoplates and instruments to help OncoMethylome study and develop DNA methylation-based biomarkers, BioTrove said.
 
OncoMethylome focuses on detecting cancer cells and using PCR tests to predict their response to treatments.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

A former Penn State Hershey Medical Center staffer has admitted to lying about skipping mandatory steps of genetic cancer tests he performed, the Associated Press reports.

The genome of a rare, red bat suggests that its effective population size has been in decline for thousands of years, according to a PLOS One study.

In Nature this week: investigation into the genetics of medulloblastoma, and more.

A project in the UK is to use genomic selection to speed spruce tree growth, according to Innovators Magazine.